Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
about
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizuresLevetiracetam in the treatment of epilepsyComparative monotherapy trials and the clinical treatment of epilepsyAn Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic DrugsA microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brainRapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometryThe anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currentsLevetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies.Acute mania associated with levetiracetam treatment.An assessment of levetiracetam as an anti-epileptic drug.Strategies for optimizing antiepileptic drug therapy in elderly people.The importance of drug interactions in epilepsy therapy.Pharmacokinetic considerations in prescribing antiepileptic drugs.Pharmacokinetics of levetiracetam.New treatment options in status epilepticus: a critical review on intravenous levetiracetam.Levetiracetam: a novel antiepileptic drug.Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.Newer therapies in the drug treatment of epilepsy.Levetiracetam: a different approach to the pharmacotherapy of epilepsy.Clinical pharmacology and therapeutic use of the new antiepileptic drugs.Using the new antiepilepsy drugs in children.Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by LevetiracetamThe ideal characteristics of antiepileptic therapy: an overview of old and new AEDs.Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expressionLevetiracetam: treatment in epilepsy.Trigeminal neuralgia: current treatments and future developments.Therapeutic drug monitoring of old and newer anti-epileptic drugs.Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsyCurrently available antiepileptic drugs.Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.The safety of levetiracetam.Seizure treatment in transplant patients.Levetiracetam rectal administration in healthy dogs.Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures.Levetiracetam in the treatment of childhood epilepsy.The seizuring cat. Diagnostic work-up and therapy.Drug interactions involving the new second- and third-generation antiepileptic drugs.Levetiracetam: a comprehensive review.
P2860
Q24650880-F18B33EE-7423-445F-8823-7A4AF6CB899FQ24656333-66EF5A8F-B9DC-4BE1-9726-E7F6389C2E55Q24673196-5075865B-A900-4A6D-BE19-359C7FD99319Q28069989-DDC2C6C9-0653-46D8-87A0-B5CDB208A068Q28343920-54F59904-C079-4424-8898-BD9D9A44A030Q28544793-33B83AE6-0E35-4569-9EEF-EDD507CA3953Q30498688-30D7434E-6173-451A-9ED7-EB7DDCB90D18Q30884717-78526A7F-524A-4764-94F8-8AD052181F55Q33569536-E8082F2A-1164-44C3-8110-C1125C15CDF6Q33709815-CEB5092D-ED2F-4E0B-BAA0-ED7068B0CD37Q33887278-103CF3A2-B3EA-488A-B42F-BDAB4176FACDQ34074969-8BB17D8B-74A1-432F-B277-341E691DAC9EQ34118987-4A2334C4-780C-4AD7-96A2-E6A7BF3D3DC8Q34123652-98FEBE6E-B2AB-412E-BD72-AC0679212F07Q34374256-E12C2069-9AC6-461A-B618-63CDE77DF125Q34374263-B97A0791-3B3A-45EF-859E-8940DC5508B7Q34409333-CB218C16-1982-4ACD-B631-D3876394DA63Q34443362-7A7F4079-7BC3-4D12-84AA-991DB6CE3733Q34469479-A45313F1-FF49-4F49-A408-C8A7CCBEDA48Q34509364-52B34999-958A-46C3-A600-D837DA68C3BDQ34533863-7031C3EC-BDEF-4445-8147-19360735144CQ34541736-C2F9A3E9-1566-4B3F-9A37-11F85FCDA443Q34579459-80646720-F264-43B3-A165-B680577F9AD0Q34965419-9309541A-7FF7-41DD-B89F-C2405251C870Q35064294-D9DA1B44-993F-433A-B994-297E27246821Q35252029-21069FD4-09F4-40BE-AC0D-A71B9824BF00Q35575012-3D01D017-BEFF-4B96-8290-15D5C791C56DQ35581154-9FED1B24-A62D-4339-9C97-489B3CA9D96CQ35970354-2EE9FBD7-0EC8-4348-AFFE-FFE3D2EAF8A7Q36033776-5527B612-89AA-43A6-BBDE-7877E62CA9ECQ36697463-F709E5EC-5047-4097-9577-66996CA5CCD6Q36802676-7D7F2172-891A-4B7E-9706-550F0A39019BQ36811528-D2727904-23F0-48F8-8809-82DA2730A10CQ36851252-B1EF7964-1B4F-46CC-A88F-1FA1BE426632Q36873335-1A4E5E4D-6543-43A2-86DA-EB522A7B9678Q36873888-9D855210-A22B-4F2E-B489-212C180DC491Q37126800-ED7CD9E0-3616-4CCA-BBA2-E44894130160Q37457534-FDAA666E-B566-4C1E-9E2B-97BAE1B367D7Q37658910-E9BD9C25-A951-428A-AF34-DFF3B7368222Q37688063-B6EB3CB5-709B-4AE7-94D0-6363FC4484A3
P2860
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@ast
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@en
type
label
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@ast
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@en
prefLabel
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@ast
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@en
P1476
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
@en
P2093
Patsalos PN
P356
10.1016/S0163-7258(99)00052-2
P577
2000-02-01T00:00:00Z